» Articles » PMID: 33587898

Genomic-informed Pathogen Surveillance in Africa: Opportunities and Challenges

Overview
Date 2021 Feb 15
PMID 33587898
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

The ongoing COVID-19 pandemic has highlighted the need to incorporate pathogen genomics for enhanced disease surveillance and outbreak management in Africa. The genomics of SARS-CoV-2 has been instrumental to the timely development of diagnostics and vaccines and in elucidating transmission dynamics. Global disease control programmes, including those for tuberculosis, malaria, HIV, foodborne pathogens, and antimicrobial resistance, also recommend genomics-based surveillance as an integral strategy towards control and elimination of these diseases. Despite the potential benefits, capacity remains low for many public health programmes in Africa. The COVID-19 pandemic presents an opportunity to reassess and strengthen surveillance systems and potentially integrate emerging technologies for preparedness of future epidemics and control of endemic diseases. We discuss opportunities and challenges for integrating pathogen genomics into public health surveillance systems in Africa. Improving accessibility through the creation of functional continent-wide networks, building multipathogen sequencing cores, training a critical mass of local experts, development of standards and policies to facilitate best practices for data sharing, and establishing a community of practice of genomics experts are all needed to use genomics for improved disease surveillance in Africa. Coordination and leadership are also crucial, which the Africa Centres for Disease Control and Prevention seeks to provide through its institute for pathogen genomics.

Citing Articles

Embedding risk monitoring in infectious disease surveillance for timely and effective outbreak prevention and control.

Ingelbeen B, van Kleef E, Mbala P, Danis K, Macicame I, Hens N BMJ Glob Health. 2025; 10(2).

PMID: 39961690 PMC: 11836831. DOI: 10.1136/bmjgh-2024-016870.


Improving Nanopore sequencing-based core genome MLST for global infection control: a strategy for GC-rich pathogens like .

Weigl S, Dabernig-Heinz J, Granitz F, Lipp M, Ostermann L, Harmsen D J Clin Microbiol. 2025; 63(3):e0156924.

PMID: 39912668 PMC: 11898673. DOI: 10.1128/jcm.01569-24.


Prioritizing post-COVID-19 health research in sub-Saharan Africa: A modified Delphi study for future pandemic.

Noormahomed E, Reid M, Mubuuke A, Gachuno O, Sewankambo N, Tsegaye A Sci Afr. 2025; 23.

PMID: 39822262 PMC: 11737301. DOI: 10.1016/j.sciaf.2024.e02103.


Genomic and epidemiological analysis of SARS-CoV-2 variants isolated in Guinea: a routine sequencing implementation.

Mbaye A, Diallo H, Gnimadi T, Kadio K, Soumah A, Koivogui J BMC Infect Dis. 2025; 25(1):3.

PMID: 39748303 PMC: 11696909. DOI: 10.1186/s12879-024-10411-2.


Adding Virome Capture Metagenomic Sequencing to Conventional Laboratory Testing Increases Unknown Fever Etiology Determination in Bamako, Mali.

Kone A, Kane F, Neal A, Konate I, Coulibaly B, Dabitao D Am J Trop Med Hyg. 2024; 112(3):626-635.

PMID: 39719110 PMC: 11884276. DOI: 10.4269/ajtmh.24-0449.


References
1.
Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K . SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020; 65(12):1075-1082. PMC: 7375454. DOI: 10.1038/s10038-020-0808-9. View

2.
Corman V, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D . Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3). PMC: 6988269. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045. View

3.
Tessema S, Raman J, Duffy C, Ishengoma D, Amambua-Ngwa A, Greenhouse B . Applying next-generation sequencing to track falciparum malaria in sub-Saharan Africa. Malar J. 2019; 18(1):268. PMC: 6720407. DOI: 10.1186/s12936-019-2880-1. View

4.
Inzaule S, Ondoa P, Peter T, Mugyenyi P, Stevens W, Wit T . Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa. Lancet Infect Dis. 2016; 16(11):e267-e275. DOI: 10.1016/S1473-3099(16)30118-9. View

5.
Lee E, Gao F, Sandstrom P, Ji H . External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges. Viruses. 2020; 12(5). PMC: 7291216. DOI: 10.3390/v12050550. View